Protective role of lithium during aluminium-induced neurotoxicity

Neurochemistry International

Volumn 56, Issue 2, 2010, Pages 256-262

  Bhalla, Punita ^a   Garg, M L ^a   Dhawan, D K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Aluminium toxicity; Behavior; Lithium; Neurotransmission

Indexed keywords

ACETYLCHOLINESTERASE; ALUMINUM; AMINE OXIDASE (FLAVIN CONTAINING); DOPAMINE; LITHIUM; REACTIVE OXYGEN METABOLITE; SEROTONIN;

ALUMINUM OVERLOAD; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN REGION; CEREBELLUM; COGNITION; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; LOCOMOTION; MAZE TEST; MUSCLE CONTRACTION; NEUROCHEMISTRY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; ROTAROD TEST; SHORT TERM MEMORY; SYNAPSE; TREATMENT DURATION;

ALUMINUM; ANIMALS; BEHAVIOR, ANIMAL; FEMALE; LITHIUM COMPOUNDS; MICROSCOPY, ELECTRON, TRANSMISSION; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION;

ANIMALIA; RATTUS;

EID: 77149169100     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.10.009     Document Type: Article

References (73)

1. Adipudi V., Reddy V.K. Effect of chronic lithium chloride on membrane adenosine triphosphatases in certain postural muscles of rats. Eur. J. Pharmacol. 1994, 259(1):7-13.
2. Amador F.C., Santos M.S., Oliveira C.R. Lipid peroxidation and aluminium effects on the cholinergic system in nerve terminals. Neurotox. Res. 2001, 3(3):223-233.
3. Berggren U. Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine-induced locomotor stimulation in rats. J. Neural. Transm. 1985, 64(3-4):239-250.
4. Bersudsky Y., Shaldubina A., Belmaker R.H. Lithium's effect in forced-swim test is blood level dependent but not dependent on weight loss. Behav. Pharmacol. 2007, 18:77-80.
5. Bharathi V.P., Govindaraju M., Palanisamy A.P., Sambamurti K., Rao K.S.J. Molecular toxicity of aluminium in relation to neurodegeneration. Indian J. Med. Res. 2008, 128:545-556.
6. Bishnoi M., Chopra K., Kulkarni S.K. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes. Eur. J. Pharmacol. 2006, 552:55-66.
7. Bymaster F.P., Felder C.C. Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents. Mol. Psychiatry 2002, 7(Suppl. 1):S57-S63.
8. Connor D.J., Harrell L.E., Jope R.S. Reversal of an aluminum-induced behavioral deficit by administration of deferoxamine. Behav. Neurosci. 1989, 103(4):779-783.
9. 2+ modulatory action on GABA transport in brain cortex nerve terminals. J. Inorg. Biochem. 2003, 97(1):132-142.
10. Cox R.H., Perhach J.L. A sensitive, rapid and simple method for the simultaneous spectrophotofluorometric determinations of norepinephrine, dopamine, 5-hydroxytryptamine and 5-hydroxy-indoleacetic acid in discrete areas of brain. J. Neurochem. 1973, 20:1777-1780.
11. Cucarella C., Montoliu C., Hermenegildo C., Sáez R., Manzo L., Miñana M.D., Felipo V. Chronic exposure to aluminum impairs neuronal glutamate-nitric oxide-cyclic GMP pathway. J. Neurochem. 1998, 70(4):1609-1614.
12. David G.F.X., Herbert J., Wright C.D.S. The ultrastructure of the pineal ganglion in the ferret. J. Anat. 1973, 115:79-97.
13. D'Mello S.R., Anelli R., Calissano P. Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons. Exp. Cell Res. 1994, 211(2):332-338.
14. Driver A.S., Kodavanti P.R., Mundy W.R. Age-related changes in reactive oxygen species production in rat brain homogenates. Neurotoxicol. Teratol. 2000, 22(2):175-181.
15. Du J., Gray N.A., Falke C.A., Chen W., Yuan P., Szabo S.T., Einat H., Manji H.K. Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. J. Neurosci. 2004, 24:578-6589.
16. Einat H., Manji H.K. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol. Psychiatry 2006, 59(12):1160-1171.
17. Ellman G.L., Lourtney K.D., Andres V.J. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
18. Eroĝlu L., Hizal A. Antidepressant action of lithium in behavioral despair test. Pol. J. Pharmacol. Pharm. 1987, 39(6):667-673.
19. Evans H.L. Markers of neurotoxicity: from behavior to autoantibodies against brain proteins. Clin. Chem. 1995, 41(12 Pt. 2):1874-1881.
20. Ferrie L., Young A.H., McQuade R. Effect of chronic lithium and withdrawal from chronic lithium on presynaptic dopamine function in the rat. J. Psychopharmacol. 2005, 19:229-234.
21. Flarend R., Bin T., Elmore D., Hem S.L. A preliminary study of the dermal absorption of aluminium from antiperspirants using aluminium-26. Food Chem. Toxicol. 2001, 39:163-168.
22. 26Al. Vaccine 1997, 15(12-13):1314-1318.
23. Gambarana C., Ghiglieri O., Masi F., Scheggi S., Tagliamonte A., De Montis M.G. The effects of long-term administration of rubidium or lithium on reactivity to stress and on dopamine output in the nucleus accumbens in rats. Brain Res. 1999, 826:200-209.
24. Gandhi D.N., Venkatakrishna-Bhatt H. Lithium effect: review on chemico-biologic interactions. Minerva Psychiatr. 1991, 32(4):237-244.
25. Ghoshdastidar D., Dutta R.N., Poddar M.K. In vivo distribution of lithium in plasma and brain. Indian J. Exp. Biol. 1989, 27(11):950-954.
26. Ghoshdastidar D. Long term effect of lithium on catecholamine metabolism. Indian J. Exp. Biol. 1990, 28:444-450.
27. Ghribi O., Dewitt D.A., Forbes M.S., Herman M.M., Savory J. Involvement of mitochondria and endoplasmic reticulum in regulation of apoptosis: changes in cytochrome-c, Bcl-2 and Bax in the hippocampus of aluminium treated rabbits. Brain Res. 2001, 8:764-773.
28. Gould T.D., Einat H., Bhat R., Manji H.K. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int. J. Neuropsychopharmacol. 2004, 1-4.
29. Gould T.D., Einat H., O'Donnell K.C., Picchini A.M., Schloesser R.J., Manji H.K. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 2007, 32(10):2173-2183.
30. Hänninen H., Matikainen E., Kovala T., Valkonen S., Riihimäki V. Internal load of aluminum and the central nervous system function of aluminum welders. Scand. J. Work Environ. Health 1994, 20(4):279-285.
31. Holtzman D., Hsu J.S., Deasutel M. Absence of effects of lead feedings and growth retardation on mitochondrial and microsomal cytochromes in the developing brain. Toxicol. Appl. Pharmacol. 1981, 58:48-56.
32. Hsu Y.P., Powell J.F., Sims K.B., Breakefield X.O. Molecular genetics of the monoamine oxidases. J. Neurochem. 1989, 53(1):12-18.
33. Hu H., Yang Y.J., Li X.P., Chen G.H. Effect of aluminum chloride on motor activity and species-typical behaviors in mice. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2005, 23(2):132-135.
34. Huh J.W., Choi M.M., Lee J.H., Yang S.J., Kim M.J., Choi J., Lee K.H., Lee J.E., Cho S.W. Activation of monoamine oxidase isotypes by prolonged intake of aluminum in rat brain. J. Inorg. Biochem. 2005, 99(10):2088-2091.
35. Janowsky D.S., Overstreet D.H. The role of acetylcholine mechanisms in mood disorders. Psychopharmacology. The Fourth Generation of Progress 1995, 945-956. Raven, New York. F.E. Bloom, D.J. Kupfer (Eds.).
36. Jope R.S. Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry 1999, 4:117-128.
37. Jope R.S., Walter R.W.G., Alacron R.D., Lally K.M. Cholinergic processes in blood samples from patients with major psychiatric disorders. Biol. Psychiatry 1985, 20:1258-1266.
38. Jope R.S., Simonato M., Lally K. J. Neurochem. 1987, 49:944.
39. Kaneko N., Sugioka T., Sakurai H. Aluminum compounds enhance lipid peroxidation in liposomes: insight into cellular damage caused by oxidative stress. J. Inorg. Biochem. 2007, 101(6):967-975.
40. Kaur A., Gill K.D. Disruption of neuronal calcium homeostasis after chronic aluminium toxicity in rats. Basic Clin. Pharmacol. Toxicol. 2005, 96(2):118-122.
41. Kowall N.W., Pendlebury W.W., Kesler J.B., Perl D.P., Beal M.F. Aluminium-induced neurofibrillary degeneration affects a subset of neurons in rabbit cerebral cortex, basal forebrain and upper brainstem. Neuroscience 1989, 29:329-377.
42. Kulkarni S.K. Handbook of Experimental Pharmacology 1999, Vallabh Prakashan, Delhi. 3rd edn.
43. Kumar S. Aluminium-induced changes in the rat brain serotonin system. Food Chem. Toxicol. 2002, 40:1875-1880.
44. Laakso M.L., Oja S.S. Transport of tryptophan and tyrosine in rat brain slices in the presence of lithium. Neurochem. Res. 1979, 4:411-423.
45. Le Moal M., Simon H. Mesocorticolombic dopaminergic network: functional and regulatory roles. Physiol. Rev. 1991, 71:155-234.
46. Lowry O.H., Rosebrough N.J., Farr A.L., Ranell R.J. Protein measurements with the Follin's phenol reagent. J. Biol. Chem. 1951, 193:265-275.
47. Manji H.K., Gottesman I.I., Gould T.D. Signal transduction and genes-to-behaviors pathways in psychiatric diseases. Sci. STKE 2003, (207):pe49.
48. McEwen C.M., Cohen J.D. An amineoxidase in normal human serum. J. Lab. Clin. Med. 1963, 62(5):766-776.
49. Nehru B., Bhalla P., Garg A. Evidence for centrophenoxine as a protective drug in aluminium induced behavioral and biochemical alteration in rat brain. Mol. Cell Biochem. 2006, 290(1-2):33-42.
50. Nehru B., Bhalla P., Garg A. Further evidence of centrophenoxine mediated protection in aluminium exposed rats by biochemical and light microscopy analysis. Food Chem. Toxicol. 2007, 45(12):2499-2505.
51. Nixon M.K., Hascoet M., Bourin M., Colombel M.C. Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology (Berl.) 1994, 115:59-64.
52. Platt B., Haas H., Büsselberg D. Aluminium reduces glutamate-activated currents of rat hippocampal neurones. Neuroreport 1994, 5(17):2329-2332.
53. Price L.H., Heninger G.R. Lithium in the treatment of mood disorders. N. Engl. J. Med. 1994, 331(9):591-598.
54. Ravi S.M., Prabhu B.M., Raju T.R., Bindu P.N. Long term effects of post natal aluminium exposure on acetylcholinesterase activity and biogenic amine neurotransmitters in rat brain. Indian J. Physiol. Pharmacol. 2000, 4:473-478.
55. Redrobe J.P., Bourin M. The effect of lithium administration in animal models of depression: a short review. Fundam. Clin. Pharmacol. 1999, 3:293-299.
56. Rifat S.L., Eastwood M.R., McLachlan D.R., Corey P.N. Effect of exposure of miners to aluminium powder. Lancet 1990, 336(8724):1162-1165.
57. Santibáñez M., Bolumar F., García A.M. Occupational risk factors in Alzheimer's disease: a review assessing the quality of published epidemiological studies. Occup. Environ. Med. 2007, 64(11):723-732.
58. Savory J., Ghribi O., Forbes M.S., Herman M.M. Aluminium and neuronal cell injury: inter-relationships between neurofilamentous arrays and apoptosis. J. Inorg. Biochem. 2001, 87:15-19.
59. Schwartz B.S., Stewart W.F., Bolla K.I., Simon P.D. Past adult exposure is associated with longitudinal decline in cognitive function. Neurology 2000, 55:1144-1150.
60. Shafer T.J., Mundy W.R. Effects of aluminum on neuronal signal transduction: mechanisms underlying disruption of phosphoinositide hydrolysis. Gen. Pharmacol. 1995, 26:889-895.
61. Sheard M.H., Aghajanian G.K. Neuronally activated metabolism of brain serotonin: effect of lithium. Life Sci. 1970, 9(5):285-290.
62. Smith D.F. Lithium alters the stereoselectivity of monoamine oxidase in rat brain. J. Neural Transm. 1989, 76(3):205-210.
63. Solfrizzi V., Colacicco A.M., D'Introno A., Capurso C., Parigi A.D., Capurso S.A., Torres F., Capurso A., Panza F. Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia. J. Alzheimers Dis. 2006, 10(2-3):303-330.
64. Soreq H., Seidman S. Acetylcholinesterase-new roles for an old actor. Nat. Rev. Neurosci. 2001, 2:294-302.
65. Strunecká, Grof P. The role of glucose in the pathogenesis of Alzheimer's disease revisited: what tells us the therapeutic use of lithium?. Cent. Nerv. Syst. Agents Med. Chem. 2006, 6(2):1-18.
66. Szutowicz A., Bielarczyk H., Kisielevski Y., Jankowska A., Madziar B., Tomaszewicz M. Effects of aluminum and calcium on acetyl-CoA metabolism in rat brain mitochondria. J. Neurochem. 1998, 71(6):2447-2453.
67. Tandon A., Bhalla P., Nagpaul J.P., Dhawan D.K. Effect of lithium on rat cerebrum under different dietary protein regimens. Drug Chem. Toxicol. 2006, 29(4):333-344.
68. Tenne M., Youdim M.B.H. Mao-inhibiting drugs: stereochemical aspects. Handbook of Stereoisomers. Drugs in Psychopharmacology 1984, 119-124. D.F. Smith (Ed.).
69. Tsaltas E., Kontis D., Boulougouris V., Papakosta V.M., Giannou H., Poulopoulou C., Soldatos C. Enhancing effects of chronic lithium on memory in the rat. Behav. Brain Res. 2007, 177(1):51-60.
70. Yan X.B., Wang S.S., Hou H.L., Ji R., Zhou J.N. Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia. Behav. Brain Res. 2007, 177(2):282-289.
71. Yokel R.A., Rhineheimer S.S., Brauer R.D., Sharma P., Elmore D., McNamara P.J. Aluminum bioavailability from drinking water is very low and is not appreciably influenced by stomach contents or water hardness. Toxicology 2001, 161(1-2):93-101.
72. Zatta P., Zambenedetti P., Milanese M. Activation of monoamine oxidase type-B by aluminum in rat brain homogenate. Neuroreport 1999, 10(17):3645-3648.
73. Zatta P., Ibn-Lkhayat-Idrissi M., Zambenedetti P., Kilyen M., Kiss T. In vivo and in vitro effects of aluminum on the activity of mouse brain acetylcholinesterase. Brain Res. Bull. 2002, 59(1):41-45.